Methyl benzoate as a marker for the detection of mold in indoor building materials
β Scribed by Loay Wady; Don-Roger Parkinson; Janusz Pawliszyn
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 551 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1615-9306
No coin nor oath required. For personal study only.
β¦ Synopsis
A convenient analytical method to quantify volatile organic compounds (VOCs) emitted from various building materials has not been addressed yet. This work presents a new and rapid automated method using SPME combined with GC/MS. Methyl benzoate - as a metabolic biomarker for mold growth-was used to indicate VOCs and to determine and assess mold growth on damp samples. Gypsum board and wall-board paper were used as examples of common indoor building materials. Optimized extraction conditions were carried out manually, using a GC/flame ionization detector. Moldy samples were analyzed using an automated SPME-GC/MS analysis under optimized conditions. The amount of methyl benzoate emitted from the studied samples ranged from 32 to 46 ppb, where the density of the fungal biomass was found to be 8 x 10(4) cells/mL. A relationship between the amount of fungal biomass and the emitted concentration of methyl benzoate was found and assessed based upon cultured mold samples taken from indoor building sites. The analytical method shows promise for the compound methyl benzoate, which can easily be identified at low detection limits (LOD = 3 ppb) and good linearity (>0.988), and its extraction and detection can be accomplished cleanly by current extraction techniques. Results suggest that this method with easy sample preparation can be used for quantitation and, of importance, minimal matrix effects are observed.
π SIMILAR VOLUMES
## Abstract Enzyme immunoassay (EIA) and radioimmunoassay (RIA) for the detection of antibody to hepatitis B core antigen (antiβHBc) were compared using serum specimens from Alaska Natives screened during a hepatitis B control program that were initially positive by EIA for only antiβHBc. Of 36 spe
## Abstract About 10β15% of patients with cervical cancer suffer from recurrence despite histologically negative lymph nodes (pN0). Occult micrometastases or small tumour cell clusters may contribute to disease outcome. The aim of this study was to compare at the RNA level 2 known tumourβassociated